X-Suite: Our full-stack, AI-powered therapeutics engine
Xaira bridges the digital and physical worlds. Using advanced AI models and AI-enabled tools, we decode disease biology, predict clinical response, and computationally design custom therapeutics—then test them. Every experimental result automatically sharpens the underlying models, ensuring each drug program starts smarter than the last.
X-Cell unlocks the biology
Trained on the largest single-cell genomic perturbation dataset ever generated, X-Cell is an AI model that decodes the precise cellular pathways that cause disease to reveal novel targets and mechanisms that conventional methods haven’t uncovered.
X-Design designs the therapeutics.
Built on Nobel Prize-winning computational foundations and validated in the lab, X-Design is our generative AI that designs entirely new, highly developable therapeutic molecules against complex targets. Our current focus is on antibody and protein therapeutics.
X-Patient identifies who may respond
X-Patient is our AI model that extends biological understanding of causal pathways to real patients by discerning how apparently similar disease states differ from patient to patient at a molecular, cellular, and tissue level. This ensures our therapeutic programs target clear responder populations from day one.
X-Scientist accelerates discovery, orchestrated by agents
X-Scientist is our agentic research platform: a multi-agent AI system that functions as a virtual drug hunter, leveraging X-Cell, X-Design, and X-Patient to discover disease-relevant targets, design novel therapeutics, and work alongside our scientists to validate them in our wet lab.
X-Automate proves
it in our lab
Our physical execution layer, X-Automate is high-throughput automation and physical AI robotics that run, measure, and learn from wet-lab experiments at machine speed, turning every physical trajectory into training data.
X-Pipeline consists of AI-derived therapeutics
As the real-world manifestation of our AI architecture, X-Pipeline translates predictive and generative discoveries into highly differentiated therapeutic programs spanning multiple modalities and indications. By treating every candidate program as a learning engine, we create a virtuous cycle to improve our models and turn rare medical breakthroughs into a repeatable, scalable process.
Where dry lab meets wet lab
Many companies focus on either computational data analysis or physical lab experimentation. We intentionally have both disciplines under one roof, a powerful synthesis of expertise designed to deliver for patients.
Derived from our platform to drive meaningful outcomes
Our emerging pipeline of AI-derived biologic medicines addresses complex diseases.
.avif)
